10-K Filing

STREAMEX CORP. CIK: 1530766 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001185185-20-000296`
Period End Date	20191231
Filing Date	20200313
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	bsgm-20191231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 32 Cash Flow Statement 71 Stockholders Equity 40

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$4.45M	USD	Point-in-time
Cash	`Cash`	$12.11M	USD	Point-in-time
Inventory	`InventoryNet`	$577.69K	USD	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Vendor deposits	`DepositAssets`	-	USD	Point-in-time
Vendor deposits	`DepositAssets`	$100.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$78.44K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$141.22K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.63M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.83M	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$39.67K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$32.37K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$180.37K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$44.35K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$714.34K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$268.80K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$364.54K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.12K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$850.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$27.41K	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	-	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$54.24K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$101.84K	USD	Point-in-time
Total assets	`Assets`	$14.22M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total assets	`Assets`	$5.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.32M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	16.87M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	40.33M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	16.87M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time
Accounts payable and accrued expenses, including $39,674 and $32,366 to related parties as of December 31, 2019 and 2018, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$954.65K	USD	Point-in-time
Accounts payable and accrued expenses, including $39,674 and $32,366 to related parties as of December 31, 2019 and 2018, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.49M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$242.91K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$128.48K	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$412.29K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.03M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.20M	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$311.13K	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Total debt	`LiabilitiesNoncurrent`	$1.20M	USD	Point-in-time
Total debt	`LiabilitiesNoncurrent`	$2.34M	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$475.00K	USD	Point-in-time
Convertible Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$215.00K	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 23,323,087 and 16,868,783 issued and outstanding as of December 31, 2019 and 2018, respectively	`CommonStockValue`	$23.32K	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 23,323,087 and 16,868,783 issued and outstanding as of December 31, 2019 and 2018, respectively	`CommonStockValue`	$16.87K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$115.91M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$74.04M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-70.73M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-104.79M	USD	Point-in-time
Total stockholders' equity attributable to BioSig Technologies, Inc	`StockholdersEquity`	$3.32M	USD	Point-in-time
Total stockholders' equity attributable to BioSig Technologies, Inc	`StockholdersEquity`	$11.15M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	-	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$514.83K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.25M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$5.00M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$14.22M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$9.74M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.37M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$12.88M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$24.81M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.40K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$54.35K	USD	Annual
Total operating expenses	`OperatingExpenses`	$34.60M	USD	Annual
Total operating expenses	`OperatingExpenses`	$17.26M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-34.60M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-17.26M	USD	Annual
Interest income, net	`InterestIncomeExpenseNet`	$10.90K	USD	Annual
Interest income, net	`InterestIncomeExpenseNet`	$132.75K	USD	Annual
Gain on disposal of assets	`GainLossOnDispositionOfAssets1`	$452.00	USD	Annual
Gain on disposal of assets	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-17.25M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-34.47M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`ProfitLoss`	$-34.47M	USD	Annual
Net loss	`ProfitLoss`	$-17.25M	USD	Annual
Preferred stock dividend	`DividendsPreferredStock`	$884.74K	USD	Annual
Preferred stock dividend	`DividendsPreferredStock`	$25.16K	USD	Annual
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-34.50M	USD	Annual
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-18.14M	USD	Annual
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$415.85K	USD	Annual
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
NET LOSS ATTRIBUTABLE TO BIOSIG TECHNOLOGIES, INC.	`NetIncomeLoss`	$-18.14M	USD	Annual
NET LOSS ATTRIBUTABLE TO BIOSIG TECHNOLOGIES, INC.	`NetIncomeLoss`	$-34.08M	USD	Annual
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.65	USD	Annual
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.25	USD	Annual
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	14.50M	shares	Annual
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.69M	shares	Annual

Cash Flow Statement 71 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-34.47M	USD	Annual
Net loss	`ProfitLoss`	$-17.25M	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$12.40K	USD	Annual
Depreciation	`DepreciationDepletionAndAmortization`	$54.35K	USD	Annual
Gain on disposal of equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$452.00	USD	Annual
Gain on disposal of equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Equity based compensation	`ShareBasedCompensation`	$15.18M	USD	Annual
Equity based compensation	`ShareBasedCompensation`	$6.60M	USD	Annual
Fair value of warrants to acquire research and development	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Fair value of warrants to acquire research and development	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.16M	USD	Annual
Change in fair value of modified options	`OtherNoncashExpense`	-	USD	Annual
Change in fair value of modified options	`OtherNoncashExpense`	$666.06K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	-	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$577.69K	USD	Annual
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	-	USD	Annual
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	$-100.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$90.19K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$61.50K	USD	Annual
Payment of long term deposit	`IncreaseDecreaseInDeposits`	$-37.15K	USD	Annual
Payment of long term deposit	`IncreaseDecreaseInDeposits`	$-47.60K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$478.75K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$537.50K	USD	Annual
Lease liability, net	`IncreaseDecreaseInOtherOperatingLiabilities`	$5.70K	USD	Annual
Lease liability, net	`IncreaseDecreaseInOtherOperatingLiabilities`	-	USD	Annual
Deferred rent payable	`IncreaseDecreaseInDeferredCharges`	$-2.81K	USD	Annual
Deferred rent payable	`IncreaseDecreaseInDeferredCharges`	-	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-15.48M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.26M	USD	Annual
Proceeds from disposal of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.75K	USD	Annual
Proceeds from disposal of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Payments of patent costs	`PaymentsToAcquireIntangibleAssets`	$268.80K	USD	Annual
Payments of patent costs	`PaymentsToAcquireIntangibleAssets`	$111.32K	USD	Annual
Payment of trademark costs	`PaymentsToAcquireOtherProductiveAssets`	$850.00	USD	Annual
Payment of trademark costs	`PaymentsToAcquireOtherProductiveAssets`	$275.00	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$38.03K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$177.09K	USD	Annual
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-307.68K	USD	Annual
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-285.93K	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.01M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.14M	USD	Annual
Proceeds from sale of subsidiary stock to non-controlling interest	`ProceedsFromMinorityShareholders`	-	USD	Annual
Proceeds from sale of subsidiary stock to non-controlling interest	`ProceedsFromMinorityShareholders`	$5.01M	USD	Annual
Proceeds from sale of Series E preferred stock	`ProceedsFromOtherEquity`	-	USD	Annual
Proceeds from sale of Series E preferred stock	`ProceedsFromOtherEquity`	$1.49M	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$2.22M	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$7.47M	USD	Annual
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$938.03K	USD	Annual
Proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$615.60K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.47M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$23.43M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$2.90M	USD	Annual
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$7.66M	USD	Annual
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.45M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.55M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.45M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.55M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	-	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	-	USD	Annual
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Reclassify derivative liability to equity	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$3.04M	USD	Point-in-time
Reclassify derivative liability to equity	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$3.04M	USD	Annual
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$884.74K	USD	Annual
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$25.16K	USD	Annual
Right-to-use assets and lease liability recorded upon adoption of ASC 842	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	$422.21K	USD	Annual
Right-to-use assets and lease liability recorded upon adoption of ASC 842	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	-	USD	Annual
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$419.00K	USD	Point-in-time
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$511.24K	USD	Annual
Record right-to-use assets and related lease liability	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	Annual

Stockholders Equity 40 line items

Line Item	Tag	Value	Unit	Period
Exercise of warrants	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$4.38	USD	Point-in-time
Exercise of warrants	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$6.53	USD	Point-in-time
Exercise of warrants	`ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1`	$6.85	USD	Point-in-time
Exercise of options	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$5.44	USD	Annual
Exercise of options	`ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice`	$4.40	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.25M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	16.87M	shares	Point-in-time
Fair value reclassification	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$3.04M	USD	Point-in-time
Fair value reclassification	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$3.04M	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$4.24M	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$9.68M	USD	Annual
Common stock issued for services (in Shares)	`StockIssuedDuringPeriodSharesIssuedForServices`	897,050.00	shares	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$10.01M	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$9.14M	USD	Annual
Sale of subsidiary shares to non-controlling interest	`StockholdersEquityOther`	$5.01M	USD	Annual
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrants`	$2.22M	USD	Annual
Common stock issued upon conversion of preferred stock and accrued dividends (in Shares)	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	17,138.00	shares	Point-in-time
Fair value of warrants issued to acquire research and development	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$3.16M	USD	Annual
Change in fair value of modified options	`OtherNoncashExpense`	-	USD	Annual
Change in fair value of modified options	`OtherNoncashExpense`	$666.06K	USD	Annual
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.36M	USD	Annual
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.50M	USD	Annual
Preferred Stock dividend	`DividendsPreferredStock`	$884.74K	USD	Annual
Preferred Stock dividend	`DividendsPreferredStock`	$25.16K	USD	Annual
Net loss	`NetIncomeLoss`	$-18.14M	USD	Annual
Net loss	`NetIncomeLoss`	$-34.08M	USD	Annual
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	10,610.00	shares	Point-in-time
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	28,077.00	shares	Point-in-time
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	7,254.00	shares	Point-in-time
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	550,077.00	shares	Annual
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	140,001.00	shares	Annual
Common stock issued upon exercise of options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	46,847.00	shares	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-3.25M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	16.87M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.